Dare Bioscience
DARE
29 hedge funds and large institutions have $7.11M invested in Dare Bioscience in 2023 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 10 reducing their positions, and 4 closing their positions.
22% more capital invested
Capital invested by funds: $5.82M → $7.11M (+$1.29M)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0.01% less ownership
Funds ownership: 0.69% → 0.68% (-0.01%)
3% less funds holding
Funds holding: 30 → 29 (-1)
25% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 4
30% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 10
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$271K |
| 2 |
Renaissance Technologies
New York
|
+$75.6K |
| 3 |
Jane Street
New York
|
+$58.8K |
| 4 |
State Street
Boston,
Massachusetts
|
+$23.9K |
| 5 |
BPA
Beacon Pointe Advisors
Newport Beach,
California
|
+$12.4K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$101K |
| 2 |
BlackRock
New York
|
-$99.5K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
-$83.2K |
| 4 |
Morgan Stanley
New York
|
-$71.9K |
| 5 |
SAM
Soviero Asset Management
New York
|
-$55.3K |
DARE Hedge Fund Activity: Q1 2023 in Review
29 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Dare Bioscience (DARE) for Q1 2023, worth a combined $7.11M — up 22% from $5.82M a quarter earlier.
Sellers outnumbered buyers: 4 funds closed out of DARE and 3 opened new positions — a net loss of 1 holder — while 10 trimmed existing stakes and 7 added.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $271K. The largest seller was Millennium Management, exiting entirely with an estimated $101K sold.
- 29 institutional investors held Dare Bioscience (DARE) as of Q1 2023, down from 30 in Q4 2022.
- Funds reported $7.11M of Dare Bioscience stock for Q1 2023, up 22% quarter-over-quarter.
- 3 funds opened new Dare Bioscience positions in Q1 2023 and 4 closed out, a net change of -1 holder.
- The largest Dare Bioscience buyer in Q1 2023 was Citadel Advisors, an estimated $271K added.
- The largest Dare Bioscience seller in Q1 2023 was Millennium Management, an estimated $101K sold.
Based on aggregated 13F filings for Q1 2023.